Biomarkers of Cardioembolic Stroke in Thrombus Composition: Diagnostic Value of DNA and Fibrin Content
European Journal of Neurology · 2026
DOI: 10.1111/ene.70484 ↗At a glance
Journal article in European Journal of Neurology, 2026. Written by Jéromine Fasille and 15 co-authors. Institution: Université de Paris Cité, Optimisation Thérapeutique en Neuropharmacologie, U1144 Institut National de la Santé et de la Recherche Médicale (INSERM),…. Major MEDLINE topics: Embolic Stroke, Fibrin Fibrinogen Degradation Products, Thrombosis, DNA. 27 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Topics: Schlaganfall
Abstract (original language)
Background and Purpose Cryptogenic strokes, accounting for 25%–40% of ischemic strokes, represent a major challenge in secondary prevention due to their uncertain etiology and high recurrence risk. Identifying biomarkers to reliably distinguish cardioembolic (CE) strokes among embolic strokes of undetermined source (ESUS) could help guide therapeutic decisions. Previous studies have indicated thrombus DNA content as a potential biomarker of CE stroke etiology, but direct quantification of fibrin, another key component, has not been adequately explored.
Methods
We analyzed thrombi collected from 186 ischemic stroke patients undergoing endovascular treatment between 2019 and 2023. Thrombi were processed using a quantitative method based on ex vivo tPA‐mediated fibrinolysis followed by mechanical homogenization. Stroke etiology was classified according to TOAST criteria: 40% cardioembolic, 24% non‐cardioembolic (large artery atherosclerosis or dissection), and 36% ESUS. Biomarker content was correlated with stroke etiology, and the diagnostic performance of DNA and fibrin (D‐dimer) content was evaluated.
Results
Cardioembolic thrombi contained significantly higher levels of DNA (median [IQR]: 325.3 [177–484] ng/mg) and D‐dimer (17.5 [9.1–23.8] μg/mg) compared to non‐cardioembolic thrombi (DNA: 128 [76.4–263] ng/mg; D‐dimer: 11.4 [6.8–13.2] μg/mg), with no significant differences observed in heme or GPVI content. The combined use of thrombus DNA and fibrin (D‐dimer) content provided good discrimination between CE and non‐CE thrombi, with an area under the ROC curve of 0.79 (95% CI, 0.70–0.87).
Conclusion
DNA and fibrin content in thrombi are promising biomarkers for identifying cardioembolic stroke etiology. Prospective studies should evaluate their use in selecting ESUS patients who may benefit from anticoagulant therapy.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Université de Paris Cité, Optimisation Thérapeutique en Neuropharmacologie, U1144 Institut National de la Santé et de la Recherche Médicale (INSERM), FHU Neurovasc, Paris, France.
- Sorbonne Université, Paris, France.
- Univ. Lille, CHU Lille, EA 2694, Santé Publique: épidémiologie et qualité Des Soins, France.
- Department of Stroke Centre and Diagnostic and Interventional Neuroradiology, University of Versailles and Saint Quentin en Yvelines, Foch Hospital, Suresnes, France.
- Department of Interventional Neuro Radiology, Rothschild Foundation Hospital, Paris, France.
- Department of Neurology, Université Paris Cité, AP-HP, Hôpital Lariboisière, Paris, France.
ORCID profiles: Jéromine Fasille, Dorothée Faille, Laurine Bedoucha, Lucas Di Meglio
Cite
APA
Fasille, J., Nomenjanahary, M. S., Faille, D., Habay, C., Bedoucha, L., Kyheng, M., Labreuche, J., Consoli, A., Lapergue, B., Piotin, M., Blanc, R., Ho-Tin-Noé, B., Mazighi, M., Desilles, J. P., Di Meglio, L., & Compo CLOT Study Group (2026). Biomarkers of Cardioembolic Stroke in Thrombus Composition: Diagnostic Value of DNA and Fibrin Content. European Journal of Neurology. https://doi.org/10.1111/ene.70484
Vancouver
Fasille J, Nomenjanahary MS, Faille D, Habay C, Bedoucha L, Kyheng M, et al. Biomarkers of Cardioembolic Stroke in Thrombus Composition: Diagnostic Value of DNA and Fibrin Content. European Journal of Neurology. 2026. doi:10.1111/ene.70484
BibTeX
@article{Fasille2026,
author = {Fasille, Jéromine and Nomenjanahary, Mialitiana Solo and Faille, Dorothée and Habay, Capucine and Bedoucha, Laurine and Kyheng, Maeva and Labreuche, Julien and Consoli, Arturo and Lapergue, Bertrand and Piotin, Michel and Blanc, Raphael and Ho-Tin-Noé, Benoit and Mazighi, Mikael and Desilles, Jean Philippe and Di Meglio, Lucas and Compo CLOT Study Group, Compo CLOT Study Group},
title = {Biomarkers of Cardioembolic Stroke in Thrombus Composition: Diagnostic Value of DNA and Fibrin Content},
journal = {European Journal of Neurology},
year = {2026},
doi = {10.1111/ene.70484}
}
EUVIMED